The immunosequencing company boosted its total funding to more than $400m with a round backed by Celgene, Illumina, BD Biosciences and LabCorp.

Atlas Venture's tenth fund has gained investment from university endowments and surpassed its initial cap of $250m to reach $280m.

Blood tests are to become painless as Tasso gains a $2.9m grant from the Defense Advanced Research Projects Agency as its small business innovation research contract is expanded.

MeQuilibrium has raised $9m in a series B round for its stress-busting resilience programme that uses research from Pennsylvania University.

The medical device developer secured funding from backers including Knight Therapeutics as it went public in Canada through a reverse takeover.

The newly formed pharmaceutical company, backed by investors including Novo, also raised $40m to advance its lead product through clinical trials.

Celgene provided $30m as part of the deal and secured the right to eventually acquire the biotechnology company, which focuses on cancer and fibrosis.

Water vapour-based medical device developer Aegea Medical has raised $36m from new and existing investors including Covidien/Medtronic.

Two finalists in the Qualcomm Tricorder XPRIZE join forces to take the Star Trek Tricorder from fiction to fact.